367 related articles for article (PubMed ID: 7750816)
1. [Calcitonin nasal spray for Paget's disease of the bone].
Luboshitzky R; Bar-Shalom R
Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
[TBL] [Abstract][Full Text] [Related]
2. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
Reginster JY; Albert A; Franchimont P
Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575
[TBL] [Abstract][Full Text] [Related]
3. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
Gagel RF; Logan C; Mallette LE
J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
[TBL] [Abstract][Full Text] [Related]
7. The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases.
Reginster JY; Jeugmans-Huynen AM; Wouters M; Sarlet N; McIntyre HD; Franchimont P
Br J Rheumatol; 1992 Jan; 31(1):35-9. PubMed ID: 1730104
[TBL] [Abstract][Full Text] [Related]
8. [Salmon calcitonin nasal spray in the treatment of Paget's disease].
Giustina A; Macca C; Bossoni S; Romanelli G; Zuccato F
Recenti Prog Med; 1989 Nov; 80(11):599-602. PubMed ID: 2623325
[TBL] [Abstract][Full Text] [Related]
9. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
Kuhlencordt F; Ringe JD; Kruse HP
Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of Paget's disease of bone with salmon calcitonin.
Sturtridge WC; Harrison JE; Wilson DR
Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
[TBL] [Abstract][Full Text] [Related]
12. Intranasal salmon calcitonin treatment of Paget's disease of bone. Results in nine patients.
D'Agostino HR; Barnett CA; Zielinski XJ; Gordan GS
Clin Orthop Relat Res; 1988 May; (230):223-8. PubMed ID: 3365896
[TBL] [Abstract][Full Text] [Related]
13. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
Goldfield EB; Braiker BM; Prendergast JJ; Kolb FO
JAMA; 1972 Sep; 221(10):1127-9. PubMed ID: 4679000
[No Abstract] [Full Text] [Related]
14. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
Rojanasathit S; Rosenberg E; Haddad JG
Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
[No Abstract] [Full Text] [Related]
15. Treatment of Paget's disease with calcitonin.
DeRose J; Avramides A; Baker RK; Wallach S
Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
[No Abstract] [Full Text] [Related]
16. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
Chapuy MC; Meunier P; Terrier M; David L; Vignon G
Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
Avramides A; Baker RK; Wallach S
Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
[No Abstract] [Full Text] [Related]
18. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
Avramides A; Flores A; DeRose J; Wallach S
J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of drugs for Paget's disease of bone.
Reginster JY; Lecart MP
Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
[TBL] [Abstract][Full Text] [Related]
20. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
Reginster JY; Gennari C; Mautalen C; Deroisy R; Denis D; Lecart MP; Vandalem JL; Collette J; Franchimont P
Scand J Rheumatol; 1990; 19(1):83-6. PubMed ID: 2309107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
